Skip to content

Heart and Lung Function Monitoring System

Heart and Lung Function Monitoring System Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02168049
Enrollment
150
Registered
2014-06-20
Start date
2014-11-30
Completion date
2017-09-30
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Diseases, Lung Diseases

Keywords

cardiac, respiratory, monitoring

Brief summary

The investigator goal is to test a new device to see if it can provide continuous and simultaneous monitoring of heart and lung function.

Detailed description

The purpose of this study is to evaluate and guide progress in the development of a new instrument that may provide continuous, integrated monitoring of heart and lung function.

Interventions

DEVICEIntegrated CardioRespiratory System

Participants will be asked to wear a non-invasive band on their upper abdomen while laying down. This band includes acoustic sensors. A remote monitoring device will continuously monitor and record heart rate and lung volumes and function.

Participants will undergo a TTE examination. During the TTE, a technician obtains views of the heart by moving a small instrument called a transducer to different locations on the chest or abdominal wall.

DEVICEElectrocardiography

Participants will also have ECG monitoring as part of the TTE exam, which records the electrical activity of the heart using electrodes placed on the body.

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult's ≥ 18 years old

Exclusion criteria

* Wounds, surgical incisions at the site of sensor placement

Design outcomes

Primary

MeasureTime frameDescription
Acoustic heart sound electronic data60 minutes during system trialHeart and lung function monitoring

Secondary

MeasureTime frameDescription
Standard echocardiography parameters60 minutes during examination simultaneous with system trialTransthoracic Echocardiography (TTE)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026